Related Experiment Video

Updated: May 30, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Bothrops jararaca peptide with anti-hypertensive action normalizes endothelium dysfunction involved in

Gabriel Benedetti1, Katia L P Morais, Juliano R Guerreiro

  • 1Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao, Instituto Butantan, Sao Paulo, Brazil.

Plos One
|August 23, 2011
PubMed

Insights

A novel peptide, Bj-PRO-10c, from snake venom shows promise for treating preeclampsia. It boosts nitric oxide (NO) production and normalizes endothelial function in cells from preeclamptic women.

Area of Science:

  • Pharmacology
  • Obstetrics
  • Cardiovascular Research

Background:

  • Preeclampsia is a serious pregnancy disorder causing maternal and fetal complications, particularly in developing nations.
  • Existing treatments for preeclampsia are limited, highlighting the need for novel therapeutic strategies.
  • Bj-PRO-10c, a peptide from Bothrops jararaca venom, exhibits anti-hypertensive properties, with prior studies linking its effects to nitric oxide (NO) production.

Purpose of the Study:

  • To investigate the in vitro effects of Bj-PRO-10c on human umbilical vein endothelial cells (HUVEC) from women with preeclampsia (HUVEC-PE) and normotensive pregnant women (HUVEC).
  • To determine if Bj-PRO-10c can restore normal nitric oxide (NO) production and endothelial function in HUVEC-PE.
  • To explore the potential of Bj-PRO-10c as a therapeutic agent for preeclampsia.

Main Methods:

  • In vitro study using HUVEC-PE and HUVEC.
  • Measurement of NO production, endothelial nitric oxide synthase (eNOS) expression, and argininosuccinate synthase activity.
  • Assessment of intracellular calcium fluxes and superoxide production.

Main Results:

  • Bj-PRO-10c significantly increased NO production in HUVEC-PE to levels comparable to HUVEC.
  • The peptide enhanced eNOS expression and argininosuccinate synthase activity in HUVEC-PE.
  • Bj-PRO-10c inhibited excessive superoxide production and induced intracellular calcium fluxes in HUVEC-PE, leading to eNOS activation.

Conclusions:

  • Bj-PRO-10c demonstrates therapeutic potential by restoring endothelial NO production and function in preeclampsia.
  • The peptide's specific effects on HUVEC-PE suggest a targeted mechanism for treating preeclampsia.
  • Bj-PRO-10c may represent a promising novel therapeutic candidate for managing preeclampsia.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...